Leaders from the National Institute of Neurological Disorders and Stroke (NINDS), the National Institute on Drug Abuse (NIDA), the National Institute of Alcohol Abuse and Alcoholism (NIAAA), the National Institute on Mental Health (NIMH), the National Center for Complementary and Integrative Health (NCCIH), and the Eunice Kennedy Shriver National Institute of Child and Human Development (NICHD) will brief reporters about their Institutes’ research efforts related to COVID-19 and SARS-CoV-2. Topics will include Long COVID, effects of SARS-CoV-2 infection on the brain, mental health during the pandemic, and COVID-19 and the opioid epidemic.
- Walter Koroshetz, M.D., Director, NINDS
- Nora Volkow, M.D., Director, NIDA
- George Koob, Ph.D., Director, NIAAA
- Shelli Avenevoli, Ph.D., Deputy Director, NIMH
- David Shurtleff, Ph.D., Deputy Director, NCCIH
- Alison Cernich, Ph.D., Deputy Director, NICHD
Wednesday, November 3, 2021, from 10:00-11:00 a.m. ET
The press briefing will be conducted via Zoom Webinar. Reporters who would like to join the briefing should register for a Neuroscience 2021 media pass. Registration is free and includes access to all events at the 2021 Society for Neuroscience Annual Meeting.
NINDS Press Team
NIDA Press Team
NIAAA Press Contact
NIMH Press Team
NCCIH Press Team
NICHD Press Team
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.